Reach52 is a healthcare access company headquartered in Singapore that is bridging the gap in pharmaceutical distribution for underserved communities. The company partners with leading global pharmaceutical manufacturers—including Sandoz (a Novartis division), Sanofi, Bayer, Pfizer, and others—to distribute affordable, high-quality generic and essential medicines through a growing network of superstockists, stockists, doctors, and chemists across India.
Beyond its core pharmaceutical distribution business in India, Reach52 operates a pharma services arm that delivers B2B impact campaigns for global health organizations. The company's model addresses a critical market need as large multinational pharmaceutical companies increasingly exit low-margin, high-impact segments in emerging markets, creating an opportunity for specialized distributors to ensure continued access to essential medicines at scale.